Our previous studies also demonstrated that CTL inhibits breast cancer cell growth and metastasis by causing ROS-induced cell cycle arrest at the G2/M phase and inhibiting TNFα-induced NF-κB activation in both in vitro and in vivo models [44,49]. The gene discussed is NFKB1; the disease is breast carcinoma.